Planet Labs vs Vir Biotechnology Inc. Common Stock — how do they compare? Planet Labs trades at $13.5 (market cap $5.14B), while Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B). The key difference: Planet Labs is far larger — about 2.9× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Planet Labs for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| PL | VIR | |
|---|---|---|
Market Cap | $5.14B | $1.76B |
Volume | 10,732,105 | 2,764,948 |
Sector | Industrials | Health |
52-Week High | $51.40 | $11.78 |
52-Week Low | $11.16 | $5.12 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $4.77B | $1.32B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →